WeOnTech

Japan firms invest in local gas shipping company

Published: Wednesday, December 15, 2010

Nguyen Ngoc Anh (L), general director of Gas Shipping, hands the investment certificate to Hideo Katsube, chiarman and CEO of Knowledge Company Inc., in HCMC on Monday - Photo: Thuy Trieu
HCMC – Two Japanese firms have each acquired one million shares of Vietnam’s International Gas Product Shipping Joint Stock Company, or Gas Shipping, thus holding a combined stake of 6.7% in the local public company.

It was revealed at a function held in HCMC on Monday that Knowledge Company Inc. and Indochina No.1 Limited Liability Partnership had bought the two million shares from PetroVietnam Transportation Corporation (PVTrans), the parent firm of Gas Shipping which holds a controlling stake in the gas transporter.

Nguyen Ngoc Anh, general director of Gas Shipping, handed certificates recognizing the two Japanese investors as its major shareholders on Monday.

Gas Shipping, with chartered capital of VND300 billion, started operation in early 2008, with the core business being transportation of liquefied petroleum gas (LPG) as assigned by its parent firm PVTrans.

The company operates its own fleet of four vessels plus five chartered vessels. The company expects to obtain VND513 billion in revenue and VND66.4 billion in pre-tax profit, up 142% and 57% respectively from last year.

Gas Shipping is expected to list on the Hochiminh Stock Exchange in the first quarter next year.

Tags for Japan firms invest in local gas shipping company:  ShippingcompanyCompanyNguyen NgocNgoc generalgeneral directordirector Shipping
From Health

Vietnamese Health Minister visits France

Vietnamese Health Minister Nguyen Thi Kim Tien had a working session with French Minister of Social Affairs and Health Marisol Touraine during her visit to France from 16-18 May.

Experts support HPV vaccines in cancer fight

More than 150 health experts from southern provinces and cities gathered at a workshop held on May 17 in central Phan Thiet city to hear the latest research about the treatment of Human Papillomavirus (HPV)-related diseases.